期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 93, 期 2, 页码 153-158出版社
WILEY
DOI: 10.1038/clpt.2012.209
关键词
-
资金
- National Institutes of Health (NIH)
- NIH grant [GM61374]
Allopurinol is the most commonly used drug for the treatment of hyperuricemia and gout. However, allopurinol is also one of the most common causes of severe cutaneous adverse reactions (SCARs), which include drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A variant allele of the human leukocyte antigen (HLA)-B, HLA-B*58:01, associates strongly with allopurinol-induced SCAR. We have summarized the evidence from the published literature and developed peer-reviewed guidelines for allopurinol use based on HLA-B genotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据